Published in Microvasc Res on February 04, 2009
Chronic transfusion therapy improves but does not normalize systemic and pulmonary vasculopathy in sickle cell disease. Blood (2015) 1.25
Modeling particle shape-dependent dynamics in nanomedicine. J Nanosci Nanotechnol (2011) 1.14
Theoretical models for coronary vascular biomechanics: progress & challenges. Prog Biophys Mol Biol (2010) 0.96
Microhemodynamic aberrations created by transfusion of stored blood. Transfusion (2013) 0.92
Vascular targeting of nanocarriers: perplexing aspects of the seemingly straightforward paradigm. ACS Nano (2014) 0.92
Blood-plasma separation in Y-shaped bifurcating microfluidic channels: a dissipative particle dynamics simulation study. Phys Biol (2012) 0.89
A low-dimensional model for the red blood cell. Soft Matter (2010) 0.89
Investigating dynamical deformations of tumor cells in circulation: predictions from a theoretical model. Front Oncol (2012) 0.86
Predicting dynamics and rheology of blood flow: A comparative study of multiscale and low-dimensional models of red blood cells. Microvasc Res (2011) 0.84
Biomechanics of haemostasis and thrombosis in health and disease: from the macro- to molecular scale. J Cell Mol Med (2013) 0.84
Red blood cell dynamics in polymer brush-coated microcapillaries: A model of endothelial glycocalyx in vitro. Biomicrofluidics (2014) 0.82
Spatial distributions of red blood cells significantly alter local haemodynamics. PLoS One (2014) 0.81
A numerical study of blood flow using mixture theory. Int J Eng Sci (2014) 0.81
Removal of malaria-infected red blood cells using magnetic cell separators: A computational study. Appl Math Comput (2012) 0.80
Study of blood flow in several benchmark micro-channels using a two-fluid approach. Int J Eng Sci (2015) 0.80
Modeling and numerical simulation of blood flow using the Theory of Interacting Continua. Int J Non Linear Mech (2011) 0.80
Low micromolar intravascular cell-free hemoglobin concentration affects vascular NO bioavailability in sickle cell disease: a computational analysis. J Appl Physiol (1985) (2012) 0.78
Non-affinity factors modulating vascular targeting of nano- and microcarriers. Adv Drug Deliv Rev (2015) 0.78
Deformable Discoidal Polymeric Nanoconstructs for the Precise Delivery of Therapeutic and Imaging Agents. Mol Ther (2017) 0.78
Effect of deformability difference between two erythrocytes on their aggregation. Phys Biol (2013) 0.77
Microfluidic-based measurement of erythrocyte sedimentation rate for biophysical assessment of blood in an in vivo malaria-infected mouse. Biomicrofluidics (2014) 0.77
Drug carrier interaction with blood: a critical aspect for high-efficient vascular-targeted drug delivery systems. Ther Deliv (2015) 0.76
Effects of flowing RBCs on adhesion of a circulating tumor cell in microvessels. Biomech Model Mechanobiol (2016) 0.75
Impact of stochastic fluctuations in the cell free layer on nitric oxide bioavailability. Front Comput Neurosci (2015) 0.75
Circulating Tumor Cells: When a Solid Tumor Meets a Fluid Microenvironment. Adv Exp Med Biol (2016) 0.75
Two-phase model for prediction of cell-free layer width in blood flow. Microvasc Res (2012) 0.75
Computational fluid dynamics assisted characterization of parafoveal hemodynamics in normal and diabetic eyes using adaptive optics scanning laser ophthalmoscopy. Biomed Opt Express (2016) 0.75
Immersed Boundary Models for Quantifying Flow-Induced Mechanical Stimuli on Stem Cells Seeded on 3D Scaffolds in Perfusion Bioreactors. PLoS Comput Biol (2016) 0.75
Two-dimensional strain-hardening membrane model for large deformation behavior of multiple red blood cells in high shear conditions. Theor Biol Med Model (2014) 0.75
In vitro particulate analogue fluids for experimental studies of rheological and hemorheological behavior of glucose-rich RBC suspensions. Biomicrofluidics (2017) 0.75
A two phase field model for tracking vesicle-vesicle adhesion. J Math Biol (2016) 0.75
Improved measurements of the erythrocyte geometry. Microvasc Res (1972) 5.17
Bending elastic modulus of red blood cell membrane derived from buckling instability in micropipet aspiration tests. Biophys J (1983) 3.71
Blood viscosity in tube flow: dependence on diameter and hematocrit. Am J Physiol (1992) 3.10
Microcirculation and Hemorheology. Annu Rev Fluid Mech (2005) 3.08
The interaction of leukocytes and erythrocytes in capillary and postcapillary vessels. Microvasc Res (1980) 2.49
Erythrocyte membrane elasticity and viscosity. Annu Rev Physiol (1987) 2.21
A two-phase model for flow of blood in narrow tubes with increased effective viscosity near the wall. Biorheology (2001) 2.01
Depletion-mediated red blood cell aggregation in polymer solutions. Biophys J (2002) 1.61
Mesoscale simulation of blood flow in small vessels. Biophys J (2007) 1.61
Blood platelets are concentrated near the wall and red blood cells, in the center in flowing blood. Arteriosclerosis (1989) 1.57
Computational fluid dynamic simulation of aggregation of deformable cells in a shear flow. J Biomech Eng (2005) 1.40
Decreased hydrodynamic resistance in the two-phase flow of blood through small vertical tubes at low flow rates. Circ Res (1991) 1.35
Rheological effects of red blood cell aggregation in the venous network: a review of recent studies. Biorheology (2001) 1.28
Numerical simulation of the flow-induced deformation of red blood cells. Ann Biomed Eng (2003) 1.27
Particulate nature of blood determines macroscopic rheology: a 2-D lattice Boltzmann analysis. Biophys J (2004) 1.27
Computational modeling of cell adhesion and movement using a continuum-kinetics approach. Biophys J (2003) 1.26
Red cell aggregation by macromolecules: roles of surface adsorption and electrostatic repulsion. J Supramol Struct (1973) 1.22
Blood viscosity in small tubes: effect of shear rate, aggregation, and sedimentation. Am J Physiol (1987) 1.20
Red blood cell aggregation and dissociation in shear flows simulated by lattice Boltzmann method. J Biomech (2007) 1.14
Blood flow structure related to red cell flow: determinant of blood fluidity in narrow microvessels. Jpn J Physiol (2001) 1.13
Blood rheology: effect of fibrinogen deduced by addition. Circ Res (1966) 1.09
A computer-based method for determination of the cell-free layer width in microcirculation. Microcirculation (2006) 1.06
Transient rheological behavior of blood in low-shear tube flow: velocity profiles and effective viscosity. Am J Physiol (1995) 0.97
An immersed boundary lattice Boltzmann approach to simulate deformable liquid capsules and its application to microscopic blood flows. Phys Biol (2007) 0.97
Basic phenomena of red blood cell rouleaux formation. Biorheology (1999) 0.95
Hemodynamic effects of red blood cell aggregation. Indian J Exp Biol (2007) 0.86
Mean-field free-energy approach to the lattice Boltzmann method for liquid-vapor and solid-fluid interfaces. Phys Rev E Stat Nonlin Soft Matter Phys (2004) 0.86
Effects of sedimentation of small red blood cell aggregates on blood flow in narrow horizontal tubes. Biorheology (1997) 0.79
Pressure boundary condition of the lattice Boltzmann method for fully developed periodic flows. Phys Rev E Stat Nonlin Soft Matter Phys (2006) 0.79
Microcirculation and Hemorheology. Annu Rev Fluid Mech (2005) 3.08
Effect of vapor source-building separation and building construction on soil vapor intrusion as studied with a three-dimensional numerical model. Environ Sci Technol (2005) 2.73
Oxygen gradients in the microcirculation. Physiol Rev (2003) 2.53
Simulating the effect of aerobic biodegradation on soil vapor intrusion into buildings: influence of degradation rate, source concentration, and depth. Environ Sci Technol (2006) 2.53
Effect of tumor microenvironment on tumor VEGF during anti-VEGF treatment: systems biology predictions. J Natl Cancer Inst (2013) 1.75
Lowering of blood pressure by increasing hematocrit with non nitric oxide scavenging red blood cells. Am J Respir Cell Mol Biol (2007) 1.70
A systems biology perspective on sVEGFR1: its biological function, pathogenic role and therapeutic use. J Cell Mol Med (2009) 1.59
A theoretical model of type I collagen proteolysis by matrix metalloproteinase (MMP) 2 and membrane type 1 MMP in the presence of tissue inhibitor of metalloproteinase 2. J Biol Chem (2004) 1.51
A compartment model of VEGF distribution in blood, healthy and diseased tissues. BMC Syst Biol (2008) 1.50
Temporal and spatial variations of cell-free layer width in arterioles. Am J Physiol Heart Circ Physiol (2007) 1.46
Systems biology of vascular endothelial growth factors. Microcirculation (2008) 1.41
Computational fluid dynamic simulation of aggregation of deformable cells in a shear flow. J Biomech Eng (2005) 1.40
Model of competitive binding of vascular endothelial growth factor and placental growth factor to VEGF receptors on endothelial cells. Am J Physiol Heart Circ Physiol (2003) 1.33
Anti-angiogenic peptides for cancer therapeutics. Curr Pharm Biotechnol (2011) 1.32
Multiscale models of angiogenesis. IEEE Eng Med Biol Mag (2009) 1.26
Increase of plasma VEGF after intravenous administration of bevacizumab is predicted by a pharmacokinetic model. Cancer Res (2010) 1.22
Reactive oxygen species regulate hypoxia-inducible factor 1alpha differentially in cancer and ischemia. Mol Cell Biol (2008) 1.21
Interactions of VEGF isoforms with VEGFR-1, VEGFR-2, and neuropilin in vivo: a computational model of human skeletal muscle. Am J Physiol Heart Circ Physiol (2006) 1.21
Effect of aggregation and shear rate on the dispersion of red blood cells flowing in venules. Am J Physiol Heart Circ Physiol (2002) 1.20
A computational model of intracellular oxygen sensing by hypoxia-inducible factor HIF1 alpha. J Cell Sci (2006) 1.20
VEGF gradients, receptor activation, and sprout guidance in resting and exercising skeletal muscle. J Appl Physiol (1985) (2006) 1.20
Blood flow and cell-free layer in microvessels. Microcirculation (2010) 1.19
A biochemical model of matrix metalloproteinase 9 activation and inhibition. J Biol Chem (2007) 1.18
Experimental and theoretical studies of oxygen gradients in rat pial microvessels. J Cereb Blood Flow Metab (2008) 1.18
Dimerization of VEGF receptors and implications for signal transduction: a computational study. Biophys Chem (2007) 1.18
Targeting neuropilin-1 to inhibit VEGF signaling in cancer: Comparison of therapeutic approaches. PLoS Comput Biol (2006) 1.17
A systematic methodology for proteome-wide identification of peptides inhibiting the proliferation and migration of endothelial cells. Proc Natl Acad Sci U S A (2008) 1.16
Nitric oxide in the vasculature: where does it come from and where does it go? A quantitative perspective. Antioxid Redox Signal (2008) 1.16
Distinct modes of collagen type I proteolysis by matrix metalloproteinase (MMP) 2 and membrane type I MMP during the migration of a tip endothelial cell: insights from a computational model. J Theor Biol (2005) 1.16
The cell-free layer in microvascular blood flow. Biorheology (2009) 1.15
Theoretical analysis of biochemical pathways of nitric oxide release from vascular endothelial cells. Free Radic Biol Med (2006) 1.15
Red blood cell aggregation and dissociation in shear flows simulated by lattice Boltzmann method. J Biomech (2007) 1.14
Predicting the effects of anti-angiogenic agents targeting specific VEGF isoforms. AAPS J (2012) 1.14
Quantification and cell-to-cell variation of vascular endothelial growth factor receptors. Exp Cell Res (2010) 1.14
Effect of outer hair cell piezoelectricity on high-frequency receptor potentials. J Acoust Soc Am (2003) 1.13
Erythrocyte consumption of nitric oxide in presence and absence of plasma-based hemoglobin. Am J Physiol Heart Circ Physiol (2002) 1.13
Differential binding of VEGF isoforms to VEGF receptor 2 in the presence of neuropilin-1: a computational model. Am J Physiol Heart Circ Physiol (2005) 1.11
Computational model of vascular endothelial growth factor spatial distribution in muscle and pro-angiogenic cell therapy. PLoS Comput Biol (2006) 1.10
Elongation, proliferation & migration differentiate endothelial cell phenotypes and determine capillary sprouting. BMC Syst Biol (2009) 1.10
Peptides derived from type IV collagen, CXC chemokines, and thrombospondin-1 domain-containing proteins inhibit neovascularization and suppress tumor growth in MDA-MB-231 breast cancer xenografts. Neoplasia (2009) 1.10
A compartment model of VEGF distribution in humans in the presence of soluble VEGF receptor-1 acting as a ligand trap. PLoS One (2009) 1.09
Contribution of nNOS- and eNOS-derived NO to microvascular smooth muscle NO exposure. J Appl Physiol (1985) (2004) 1.07
A computer-based method for determination of the cell-free layer width in microcirculation. Microcirculation (2006) 1.06
Systems biology of pro-angiogenic therapies targeting the VEGF system. Wiley Interdiscip Rev Syst Biol Med (2010) 1.06
Oxygen transport from the atmosphere to soil gas beneath a slab-on-grade foundation overlying petroleum-impacted soil. Environ Sci Technol (2008) 1.05
Wall shear stress differentially affects NO level in arterioles for volume expanders and Hb-based O2 carriers. Microvasc Res (2003) 1.05
Module-based multiscale simulation of angiogenesis in skeletal muscle. Theor Biol Med Model (2011) 1.04
Nitric oxide from nitrite reduction by hemoglobin in the plasma and erythrocytes. Nitric Oxide (2007) 1.03
Model of nitric oxide diffusion in an arteriole: impact of hemoglobin-based blood substitutes. Am J Physiol Heart Circ Physiol (2002) 1.03
Identification of novel short peptides derived from the alpha 4, alpha 5, and alpha 6 fibrils of type IV collagen with anti-angiogenic properties. Biochem Biophys Res Commun (2007) 1.03
Multi-scale computational models of pro-angiogenic treatments in peripheral arterial disease. Ann Biomed Eng (2007) 1.03
A reaction-diffusion model of basic fibroblast growth factor interactions with cell surface receptors. Ann Biomed Eng (2004) 1.02
Calculations of oxygen transport by red blood cells and hemoglobin solutions in capillaries. Artif Cells Blood Substit Immobil Biotechnol (2002) 1.00
A computational model of oxygen transport in skeletal muscle for sprouting and splitting modes of angiogenesis. J Theor Biol (2006) 1.00
Relationship between erythrocyte aggregate size and flow rate in skeletal muscle venules. Am J Physiol Heart Circ Physiol (2003) 1.00
Intracoronary administration of FGF-2: a computational model of myocardial deposition and retention. Am J Physiol Heart Circ Physiol (2004) 1.00
Compartment model predicts VEGF secretion and investigates the effects of VEGF trap in tumor-bearing mice. Front Oncol (2013) 0.99
A computational model of oxygen delivery by hemoglobin-based oxygen carriers in three-dimensional microvascular networks. J Theor Biol (2007) 0.98
Pharmacokinetics and pharmacodynamics of VEGF-neutralizing antibodies. BMC Syst Biol (2011) 0.98
Three autocrine feedback loops determine HIF1 alpha expression in chronic hypoxia. Biochim Biophys Acta (2007) 0.97
Skeletal muscle VEGF gradients in peripheral arterial disease: simulations of rest and exercise. Am J Physiol Heart Circ Physiol (2007) 0.97
An immersed boundary lattice Boltzmann approach to simulate deformable liquid capsules and its application to microscopic blood flows. Phys Biol (2007) 0.97
The effect of small changes in hematocrit on nitric oxide transport in arterioles. Antioxid Redox Signal (2010) 0.97
Aggregate formation of erythrocytes in postcapillary venules. Am J Physiol Heart Circ Physiol (2004) 0.96
Theoretical models for coronary vascular biomechanics: progress & challenges. Prog Biophys Mol Biol (2010) 0.96
The presence of VEGF receptors on the luminal surface of endothelial cells affects VEGF distribution and VEGF signaling. PLoS Comput Biol (2009) 0.96
Inhibition of lymphangiogenesis and angiogenesis in breast tumor xenografts and lymph nodes by a peptide derived from transmembrane protein 45A. Neoplasia (2013) 0.96
Increased cardiac output and microvascular blood flow during mild hemoconcentration in hamster window model. Am J Physiol Heart Circ Physiol (2006) 0.95
Temporal variability of indoor air concentrations under natural conditions in a house overlying a dilute chlorinated solvent groundwater plume. Environ Sci Technol (2013) 0.94
Formation of VEGF isoform-specific spatial distributions governing angiogenesis: computational analysis. BMC Syst Biol (2011) 0.94
Multiscale imaging and computational modeling of blood flow in the tumor vasculature. Ann Biomed Eng (2012) 0.94
Small peptides derived from somatotropin domain-containing proteins inhibit blood and lymphatic endothelial cell proliferation, migration, adhesion and tube formation. Int J Biochem Cell Biol (2011) 0.94
A theoretical model of nitric oxide transport in arterioles: frequency- vs. amplitude-dependent control of cGMP formation. Am J Physiol Heart Circ Physiol (2003) 0.94
Pentastatin-1, a collagen IV derived 20-mer peptide, suppresses tumor growth in a small cell lung cancer xenograft model. BMC Cancer (2010) 0.93
Hypotonic swelling of salicylate-treated cochlear outer hair cells. Hear Res (2007) 0.93
VEGF and soluble VEGF receptor-1 (sFlt-1) distributions in peripheral arterial disease: an in silico model. Am J Physiol Heart Circ Physiol (2010) 0.93
Vascular smooth muscle NO exposure from intraerythrocytic SNOHb: a mathematical model. Antioxid Redox Signal (2007) 0.92
Quantifying the proteolytic release of extracellular matrix-sequestered VEGF with a computational model. PLoS One (2010) 0.92
Effect of erythrocyte aggregation at normal human levels on functional capillary density in rat spinotrapezius muscle. Am J Physiol Heart Circ Physiol (2005) 0.92
Chlorinated ethene source remediation: lessons learned. Environ Sci Technol (2012) 0.92
Quantitative fluorescent profiling of VEGFRs reveals tumor cell and endothelial cell heterogeneity in breast cancer xenografts. Cancer Med (2014) 0.92
Microhemodynamic aberrations created by transfusion of stored blood. Transfusion (2013) 0.92
Effect of oxygen consumption by measuring method on PO2 transients associated with the passage of erythrocytes in capillaries of rat mesentery. Am J Physiol Heart Circ Physiol (2005) 0.91
Novel peptide-specific quantitative structure-activity relationship (QSAR) analysis applied to collagen IV peptides with antiangiogenic activity. J Med Chem (2011) 0.91
An experimental and theoretical study on the dissolution of mural fibrin clots by tissue-type plasminogen activator. Biotechnol Bioeng (2002) 0.90
Effect of erythrocyte aggregation and flow rate on cell-free layer formation in arterioles. Am J Physiol Heart Circ Physiol (2010) 0.90
Novel anti-angiogenic peptides derived from ELR-containing CXC chemokines. J Cell Biochem (2008) 0.90
Endothelial cell-by-cell profiling reveals the temporal dynamics of VEGFR1 and VEGFR2 membrane localization after murine hindlimb ischemia. Am J Physiol Heart Circ Physiol (2013) 0.90
Computational kinetic model of VEGF trapping by soluble VEGF receptor-1: effects of transendothelial and lymphatic macromolecular transport. Physiol Genomics (2009) 0.90
Expression of VEGF receptors on endothelial cells in mouse skeletal muscle. PLoS One (2012) 0.90